Delcath Systems, Inc.
General ticker "DCTH" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $410.6M (TTM average)
Delcath Systems, Inc. does not follow the US Stock Market performance with the rate: -5.3%.
Estimated limits based on current volatility of 2.2%: low 10.09$, high 10.54$
Factors to consider:
- Total employees count: 96 (+26.3%) as of 2024
- Top business risk factors: Insufficient funding, Product commercialization failure, Litigation risks, Intellectual property risks, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.62$, 17.06$]
- 2025-12-31 to 2026-12-31 estimated range: [4.33$, 11.77$]
Financial Metrics affecting the DCTH estimates:
- Positive: with PPE of -13.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.68 <= 0.04
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of -45.96 <= -0.76
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Negative: negative Industry operating cash flow (median)
Short-term DCTH quotes
Long-term DCTH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2.72MM | $2.06MM | $37.20MM |
| Operating Expenses | $36.57MM | $40.25MM | $49.62MM |
| Operating Income | $-33.85MM | $-38.18MM | $-12.41MM |
| Non-Operating Income | $-2.65MM | $-9.50MM | $-13.98MM |
| Interest Expense | $2.69MM | $0.00MM | $0.00MM |
| R&D Expense | $18.58MM | $17.50MM | $13.87MM |
| Income(Loss) | $-36.51MM | $-47.68MM | $-26.39MM |
| Profit(Loss)* | $-36.51MM | $-47.68MM | $-26.39MM |
| Stockholders Equity | $-5.86MM | $15.78MM | $68.75MM |
| Inventory | $2.00MM | $3.32MM | $6.93MM |
| Assets | $17.86MM | $38.61MM | $76.59MM |
| Operating Cash Flow | $-24.95MM | $-31.25MM | $-18.68MM |
| Capital expenditure | $0.21MM | $0.06MM | $0.56MM |
| Investing Cash Flow | $-0.21MM | $-19.71MM | $-0.98MM |
| Financing Cash Flow | $10.14MM | $51.78MM | $39.41MM |
| Earnings Per Share** | $-4.12 | $-2.94 | $-0.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.